HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Vinita Gupta Selected Research

PNC-28

1/2015Ex vivo Efficacy of Anti-Cancer Drug PNC-27 in the Treatment of Patient-Derived Epithelial Ovarian Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Vinita Gupta Research Topics

Disease

9Neoplasms (Cancer)
03/2021 - 01/2004
2Ovarian Neoplasms (Ovarian Cancer)
05/2017 - 01/2015
2Neoplasm Metastasis (Metastasis)
10/2012 - 08/2010
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2011 - 08/2009
1Glycogen Storage Disease Type VI (Glycogenosis Type VI)
08/2021
1Carcinoma (Carcinomatosis)
01/2020
1Renal Cell Carcinoma (Grawitz Tumor)
01/2020
1Inflammation (Inflammations)
01/2020
1Nausea
01/2018
1Multiple Myeloma
01/2018
1Vomiting
01/2018
1Diarrhea
01/2018
1Stomatitis
01/2018
1Tuberculosis (Tuberculoses)
02/2015
1Ovarian Epithelial Carcinoma
01/2015
1Prostatic Neoplasms (Prostate Cancer)
10/2012
1Lung Neoplasms (Lung Cancer)
12/2011
1Adenocarcinoma
12/2011
1Colorectal Neoplasms (Colorectal Cancer)
08/2010
1Pain (Aches)
07/2010
1Hyperalgesia
07/2010
1Cataract (Cataracts)
09/2002

Drug/Important Bio-Agent (IBA)

2Interleukin-8 (Interleukin 8)IBA
03/2021 - 01/2020
2Immune Checkpoint InhibitorsIBA
01/2020 - 12/2016
2Peptides (Polypeptides)IBA
05/2017 - 01/2015
2PNC-27IBA
05/2017 - 01/2015
2CytokinesIBA
12/2016 - 12/2011
2Biomarkers (Surrogate Marker)IBA
10/2012 - 08/2010
2Morphine (MS Contin)FDA LinkGeneric
12/2011 - 07/2010
1Prednisolone (Predate)FDA LinkGeneric
08/2021
1atezolizumabIBA
01/2020
1Proteins (Proteins, Gene)FDA Link
09/2018
1Indicators and Reagents (Reagents)IBA
09/2018
1Melphalan (Alkeran)FDA LinkGeneric
01/2018
1Proteasome InhibitorsIBA
01/2018
1Immunomodulating AgentsIBA
01/2018
1Amifostine (Ethyol)FDA LinkGeneric
01/2018
1Paclitaxel (Taxol)FDA LinkGeneric
05/2017
1Tuberculin (PPD)IBA
02/2015
1PNC-28IBA
01/2015
1Pharmaceutical PreparationsIBA
01/2015
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
10/2012
1AngiopoietinsIBA
10/2012
1ErbB Receptors (EGF Receptor)IBA
12/2011
1ImmunosorbentsIBA
12/2011
1Bromodeoxyuridine (BrdU)IBA
12/2011
1Opioid Receptors (Opioid Receptor)IBA
12/2011
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
12/2011
1Epidermal Growth Factor (EGF)IBA
12/2011
1EnzymesIBA
12/2011
1Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
08/2010
1SuspensionsIBA
08/2010
1Plasminogen Activator Inhibitor 1IBA
08/2010
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
07/2010
1Sickle HemoglobinIBA
07/2010
1Hemoglobin AIBA
07/2010
1CannabinoidsIBA
07/2010
1Analgesics (Analgesic Drugs)IBA
07/2010
1Interleukin-6 (Interleukin 6)IBA
07/2010
13- (2- hydroxy- 4- (1,1- dimethylheptyl)phenyl)- 4- (3- hydroxypropyl)cyclohexanolIBA
07/2010
1Mitogen-Activated Protein KinasesIBA
07/2010
1p38 Mitogen-Activated Protein KinasesIBA
07/2010
1Toll-Like Receptor 4IBA
07/2010
1Cannabinoid Receptor AgonistsIBA
07/2010
1Carboplatin (JM8)FDA LinkGeneric
08/2009
1Thalidomide (Thalomid)FDA Link
08/2009
1GemcitabineFDA Link
08/2009
1sphingosine 1-phosphate lyase (aldolase)IBA
01/2004
1CeramidesIBA
01/2004
1Immunologic Factors (Immunomodulators)IBA
01/2004
1sphingosine 1-phosphate (sphingosine-1-phosphate)IBA
01/2004

Therapy/Procedure

2Therapeutics
01/2020 - 01/2018
2Immunotherapy
09/2018 - 12/2016
1Cell Transplantation
01/2018
1Autologous Transplantation
01/2018
1Drug Therapy (Chemotherapy)
01/2015
1Neoadjuvant Therapy
08/2009
1Capsulorhexis
09/2002
1Vitrectomy
09/2002
1Intraocular Lenses (Intraocular Lens)
09/2002